Cargando…

Haplotype-Based Noninvasive Prenatal Diagnosis of 21 Families With Duchenne Muscular Dystrophy: Real-World Clinical Data in China

Noninvasive prenatal diagnosis (NIPD) of single-gene disorders has recently become the focus of clinical laboratories. However, reports on the clinical application of NIPD of Duchenne muscular dystrophy (DMD) are limited. This study aimed to evaluate the detection performance of haplotype-based NIPD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Lingrong, Li, Shaojun, Zhao, Zhenhua, Feng, Jun, Chen, Guangquan, Liu, Lina, Tang, Weiqin, Li, Suqing, Li, Feifei, Han, Xiujuan, Wu, Di, Zhang, Haichuan, Sun, Luming, Kong, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712857/
https://www.ncbi.nlm.nih.gov/pubmed/34970304
http://dx.doi.org/10.3389/fgene.2021.791856
_version_ 1784623649297268736
author Kong, Lingrong
Li, Shaojun
Zhao, Zhenhua
Feng, Jun
Chen, Guangquan
Liu, Lina
Tang, Weiqin
Li, Suqing
Li, Feifei
Han, Xiujuan
Wu, Di
Zhang, Haichuan
Sun, Luming
Kong, Xiangdong
author_facet Kong, Lingrong
Li, Shaojun
Zhao, Zhenhua
Feng, Jun
Chen, Guangquan
Liu, Lina
Tang, Weiqin
Li, Suqing
Li, Feifei
Han, Xiujuan
Wu, Di
Zhang, Haichuan
Sun, Luming
Kong, Xiangdong
author_sort Kong, Lingrong
collection PubMed
description Noninvasive prenatal diagnosis (NIPD) of single-gene disorders has recently become the focus of clinical laboratories. However, reports on the clinical application of NIPD of Duchenne muscular dystrophy (DMD) are limited. This study aimed to evaluate the detection performance of haplotype-based NIPD of DMD in a real clinical environment. Twenty-one DMD families at 7–12 weeks of gestation were prospectively recruited. DNA libraries of cell-free DNA from the pregnant and genomic DNA from family members were captured using a custom assay for the enrichment of DMD gene exons and spanning single-nucleotide polymorphisms, followed by next-generation sequencing. Parental haplotype phasing was based on family linkage analysis, and fetal genotyping was inferred using the Bayes factor through target maternal plasma sequencing. Finally, the entire experimental process was promoted in the local clinical laboratory. We recruited 13 complete families, 6 families without paternal samples, and 2 families without probands in which daughter samples were collected. Two different maternal haplotypes were constructed based on family members in all 21 pedigrees at as early as 7 gestational weeks. Among the included families, the fetal genotypes of 20 families were identified at the first blood collection, and a second blood collection was performed for another family due to low fetal concentration. The NIPD result of each family was reported within 1 week. The fetal fraction in maternal cfDNA ranged from 1.87 to 11.68%. In addition, recombination events were assessed in two fetuses. All NIPD results were concordant with the findings of invasive prenatal diagnosis (chorionic villus sampling or amniocentesis). Exon capture and haplotype-based NIPD of DMD are regularly used for DMD genetic diagnosis, carrier screening, and noninvasive prenatal diagnosis in the clinic. Our method, haplotype-based early screening for DMD fetal genotyping via cfDNA sequencing, has high feasibility and accuracy, a short turnaround time, and is inexpensive in a real clinical environment.
format Online
Article
Text
id pubmed-8712857
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87128572021-12-29 Haplotype-Based Noninvasive Prenatal Diagnosis of 21 Families With Duchenne Muscular Dystrophy: Real-World Clinical Data in China Kong, Lingrong Li, Shaojun Zhao, Zhenhua Feng, Jun Chen, Guangquan Liu, Lina Tang, Weiqin Li, Suqing Li, Feifei Han, Xiujuan Wu, Di Zhang, Haichuan Sun, Luming Kong, Xiangdong Front Genet Genetics Noninvasive prenatal diagnosis (NIPD) of single-gene disorders has recently become the focus of clinical laboratories. However, reports on the clinical application of NIPD of Duchenne muscular dystrophy (DMD) are limited. This study aimed to evaluate the detection performance of haplotype-based NIPD of DMD in a real clinical environment. Twenty-one DMD families at 7–12 weeks of gestation were prospectively recruited. DNA libraries of cell-free DNA from the pregnant and genomic DNA from family members were captured using a custom assay for the enrichment of DMD gene exons and spanning single-nucleotide polymorphisms, followed by next-generation sequencing. Parental haplotype phasing was based on family linkage analysis, and fetal genotyping was inferred using the Bayes factor through target maternal plasma sequencing. Finally, the entire experimental process was promoted in the local clinical laboratory. We recruited 13 complete families, 6 families without paternal samples, and 2 families without probands in which daughter samples were collected. Two different maternal haplotypes were constructed based on family members in all 21 pedigrees at as early as 7 gestational weeks. Among the included families, the fetal genotypes of 20 families were identified at the first blood collection, and a second blood collection was performed for another family due to low fetal concentration. The NIPD result of each family was reported within 1 week. The fetal fraction in maternal cfDNA ranged from 1.87 to 11.68%. In addition, recombination events were assessed in two fetuses. All NIPD results were concordant with the findings of invasive prenatal diagnosis (chorionic villus sampling or amniocentesis). Exon capture and haplotype-based NIPD of DMD are regularly used for DMD genetic diagnosis, carrier screening, and noninvasive prenatal diagnosis in the clinic. Our method, haplotype-based early screening for DMD fetal genotyping via cfDNA sequencing, has high feasibility and accuracy, a short turnaround time, and is inexpensive in a real clinical environment. Frontiers Media S.A. 2021-12-14 /pmc/articles/PMC8712857/ /pubmed/34970304 http://dx.doi.org/10.3389/fgene.2021.791856 Text en Copyright © 2021 Kong, Li, Zhao, Feng, Chen, Liu, Tang, Li, Li, Han, Wu, Zhang, Sun and Kong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Kong, Lingrong
Li, Shaojun
Zhao, Zhenhua
Feng, Jun
Chen, Guangquan
Liu, Lina
Tang, Weiqin
Li, Suqing
Li, Feifei
Han, Xiujuan
Wu, Di
Zhang, Haichuan
Sun, Luming
Kong, Xiangdong
Haplotype-Based Noninvasive Prenatal Diagnosis of 21 Families With Duchenne Muscular Dystrophy: Real-World Clinical Data in China
title Haplotype-Based Noninvasive Prenatal Diagnosis of 21 Families With Duchenne Muscular Dystrophy: Real-World Clinical Data in China
title_full Haplotype-Based Noninvasive Prenatal Diagnosis of 21 Families With Duchenne Muscular Dystrophy: Real-World Clinical Data in China
title_fullStr Haplotype-Based Noninvasive Prenatal Diagnosis of 21 Families With Duchenne Muscular Dystrophy: Real-World Clinical Data in China
title_full_unstemmed Haplotype-Based Noninvasive Prenatal Diagnosis of 21 Families With Duchenne Muscular Dystrophy: Real-World Clinical Data in China
title_short Haplotype-Based Noninvasive Prenatal Diagnosis of 21 Families With Duchenne Muscular Dystrophy: Real-World Clinical Data in China
title_sort haplotype-based noninvasive prenatal diagnosis of 21 families with duchenne muscular dystrophy: real-world clinical data in china
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712857/
https://www.ncbi.nlm.nih.gov/pubmed/34970304
http://dx.doi.org/10.3389/fgene.2021.791856
work_keys_str_mv AT konglingrong haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT lishaojun haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT zhaozhenhua haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT fengjun haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT chenguangquan haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT liulina haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT tangweiqin haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT lisuqing haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT lifeifei haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT hanxiujuan haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT wudi haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT zhanghaichuan haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT sunluming haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina
AT kongxiangdong haplotypebasednoninvasiveprenataldiagnosisof21familieswithduchennemusculardystrophyrealworldclinicaldatainchina